Rituximab therapy in steroid-resistant severe hypothyroid Grave′s ophthalmopathy
Association of Grave′s ophthalmopathy with hyperthyroidism is well known, and it has also been reported in euthyroid or hypothyroid autoimmune thyroiditis, which rarely requires treatment. Here, we report a case of bilaterally symmetrical severe corticosteroid-resistant hypothyroid Grave′s ophthalmo...
Egile Nagusiak: | Aditi Pandit, Abhay Gundgurthi, Sandeep Kharb, Karninder S Brar, M K Garg |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Saila: | Indian Journal of Endocrinology and Metabolism |
Gaiak: | |
Sarrera elektronikoa: | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=2;spage=344;epage=348;aulast=Pandit |
Antzeko izenburuak
-
Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
nork: T. S. Panevin, et al.
Argitaratua: (2023-10-01) -
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
nork: Poupak Fallahi, et al.
Argitaratua: (2021-04-01) -
Steroid Treatment Focused Management of Graves’ Ophthalmopathy
nork: Condeng Y. H., et al.
Argitaratua: (2024-09-01) -
Use of Rituximab After Orbital Decompression Surgery in Two Grave’s Ophthalmopathy Patients Progressing to Optic Neuropathy
nork: Benping Zhang, et al.
Argitaratua: (2020-10-01) -
Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts–a possible explanation of the link between smoking and Graves’ ophthalmopathy
nork: Chiaw Ling Chng, et al.
Argitaratua: (2014-06-01)